Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Anavar 10
Oxandrolone
- Compound
- Oxandrolone
- Category
- Oral Steroids
- Brand
- Anavar, Var
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 100 tabs
- Strength
- 10 mg/tab
- Route
- Oral
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for Anavar 10 are not yet published. They will be added here once testing is complete.
Product information
About Anavar 10
Oxandrolone 10 mg tablets • 100 tablets • Zyvex Pharmaceuticals
Anavar 10 mg contains oxandrolone, an oral anabolic androgenic steroid. Each tablet contains 10 mg of oxandrolone, and each pack contains 100 tablets. This prospect explains its composition, administration considerations, risks and pharmacological properties. Clinical information is for professional review and does not replace individual medical advice.
Basic Identification & Composition
Active Ingredient
Anavar 10 is an anabolic androgenic steroid. This oral formulation from Zyvex Pharmaceuticals contains 10 mg of oxandrolone per tablet.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Active ingredient | Oxandrolone |
| Strength | 10 mg per tablet |
| Package | 100 tablets |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Drug class | Anabolic androgenic steroid |
| Chemical formula of oxandrolone | C₁₉H₃₀O₃ |
| Molecular weight of oxandrolone | 306.44 g/mol |
| Manufacturer | Zyvex Pharmaceuticals |
Dosage Form
Oxandrolone 10 mg is a solid tablet taken by mouth. Tablets deliver a measured amount of active ingredient in each unit. Check the pack leaflet or ask a pharmacist before splitting or crushing a tablet.
Clinical Particulars
Anavar 10 uses
Anavar 10 from Zyvex Pharmaceuticals contains oxandrolone, an anabolic androgenic steroid. Medical uses of oxandrolone have included supporting weight gain after major surgery, chronic infection or severe trauma, limiting protein breakdown during prolonged corticosteroid treatment, and relieving bone pain associated with osteoporosis. Historical adult treatment schedules used 2.5–20 mg daily in 2–4 divided doses for 2–4 weeks, with further courses determined by clinical response. These are historical medical examples requiring individual prescribing and monitoring.
Outside medical treatment, people use oxandrolone to pursue greater muscle size, strength and a leaner physique. In a 2026 clinic study of 41 women using androgens, 88% reported oxandrolone use; intermittent oral cycles were common, and the principal goals were body composition, muscle size and strength. These reported goals describe why people take it, rather than proving benefit for every user. A general wellbeing benefit or a dosing protocol for improved wellbeing cannot be established from these observations.
Published nonmedical dosing examples vary and do not establish a standard protocol. One bodybuilding case report documented oxandrolone 20 mg daily alongside methandienone 40 mg daily, in repeated periods of three months on and one month off. This is an observed individual pattern, not evidence that the doses or schedule are common or safe: the patient developed a heart attack and subsequent coronary stent thrombosis. Combining drugs also prevents attributing the outcome to oxandrolone alone. Oxandrolone carries liver, cholesterol and hormonal risks; in women, voice deepening and other masculinising effects can persist after stopping.
Dosage and Administration
Historical adult labelling described 2.5–20 mg daily by mouth, divided into 2–4 doses, usually for 2–4 weeks. This is reference information, not a current prescription or an Oxandrolone 10 mg dosing recommendation.
Take oral medicines according to the prescriber's instructions. The 10 mg strength describes the amount in one tablet, not the total daily dose. A pharmacist should confirm whether the particular tablet can be divided accurately.
Children, older adults and people with liver or kidney disease require individual clinical assessment. Dose selection and monitoring should follow applicable prescribing information. Historical labelling states that anabolic steroids have not been shown to enhance athletic ability; it does not establish a performance-enhancement or exercise-recovery regimen.
Contraindications
Oxandrolone must not be used during pregnancy, in known or suspected prostate or male breast cancer, female breast cancer with hypercalcaemia, nephrosis or nephrotic nephritis, or hypercalcaemia. Avoid use with a known allergy to oxandrolone or any tablet ingredient.
Warnings and Precautions
Serious risks include peliosis hepatis, liver tumours, cholestatic hepatitis, jaundice and adverse cholesterol changes. Fluid retention may worsen heart, kidney or liver disease. Virilisation can be irreversible; childhood bone maturation may compromise adult height. Monitoring includes liver tests and lipids, with blood counts and other tests as clinically indicated.
Risks and Interactions
Drug & Food Interactions
Warfarin: anticoagulation and bleeding risk can increase substantially; close INR monitoring and clinician-led adjustment are required when oxandrolone is started, changed or stopped. Oral glucose-lowering medicines may have altered metabolism. Corticosteroids or ACTH may increase oedema. Thyroid-binding changes can affect laboratory interpretation.
Discuss alcohol intake and all medicines, vitamins and supplements with the prescriber or pharmacist, especially because of the liver risks. Do not change an anticoagulant or diabetes medicine without clinical advice. Follow any dietary instructions given by the treating clinician.
Pregnancy and Lactation
Pregnancy is contraindicated because fetal masculinisation may occur. Breast-milk excretion is uncertain; breastfeeding and treatment require a clinician-led decision because infant harm is possible. Gonadal suppression can impair fertility. Contact a clinician promptly if pregnancy occurs or is suspected.
Side Effects and Adverse Reactions
Adverse reactions vary between individuals. The effects below are grouped by their nature rather than assigned frequency categories.
Reported effects include acne, insomnia, breast enlargement, altered libido or sexual function, swelling, menstrual changes, voice deepening, increased facial hair, hair loss, clitoral enlargement, testicular changes and persistent erections. Some masculinising changes may persist.
Other historical reports include liver-test abnormalities, hepatic tumours, cholestatic injury, suppressed sperm production, mood changes, impaired glucose tolerance and premature growth-plate closure. Bleeding is a particular concern with anticoagulants.
Seek prompt medical care for jaundice, severe abdominal symptoms, unusual bleeding or marked swelling. Report other persistent or unexpected symptoms to a healthcare professional.
Overdose Protocol
Contact local poison-control or emergency medical services after suspected overdose. Collapse, seizures, breathing difficulty or inability to wake require emergency care. Swelling can occur. Historical labelling identifies no specific antidote.
Give responders the pack, suspected quantity, time of ingestion and details of other substances taken. Do not attempt stomach emptying at home. Emergency clinicians determine appropriate observation, investigations and supportive treatment.
Scientific & Technical Data
Pharmacodynamics
Oxandrolone has both anabolic and androgenic effects. External androgen exposure can suppress pituitary gonadotropins and the body's own testosterone production. These hormonal effects help explain its potential impact on reproductive function.
Pharmacokinetics
After oral administration, a drug must be absorbed into the circulation, distributed through the body, and ultimately eliminated through metabolism and excretion. These processes determine how exposure changes over time. Data from one tablet formulation do not, by themselves, demonstrate equivalent absorption from another.
Single-dose studies of oxandrolone reported mean elimination half-lives of 10.4 hours in younger volunteers and 13.3 hours in older subjects. Half-life describes the time taken for drug concentration to fall by approximately half during elimination; it does not specify a safe dose or dosing interval for an individual.
Storage and Handling
Store medicines containing oxandrolone at room temperature, away from excess heat and moisture. Keep tablets in their original, tightly closed container and avoid storing them in a bathroom. Follow any specific storage conditions and the expiry date printed on the medicine's packaging.
Keep the medicine out of the sight and reach of children. Do not share it with anyone else. Return expired or unwanted tablets through a pharmacy or medicine take-back programme. Do not flush tablets down the toilet.
Browse more